These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 7996716)

  • 1. [The correlation between the MICs deduced from Showa disk method and the MICs determined by micro-dilution method].
    Moroizumi S; Kasitani F; Isikawa M; Iwata M; Ohno A; Yamaguchi K
    Rinsho Byori; 1994 Oct; 42(10):1062-8. PubMed ID: 7996716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multi-center evaluation of Showa disk susceptibility to presumptively determine minimum inhibitory concentrations through linear regression analysis].
    Sato Y; Nagata K; Tasaki Y; Tosaka M; Yamane N
    Rinsho Byori; 1991 Apr; 39(4):429-36. PubMed ID: 2051626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colistin susceptibility testing by Etest and disk diffusion methods.
    Galani I; Kontopidou F; Souli M; Rekatsina PD; Koratzanis E; Deliolanis J; Giamarellou H
    Int J Antimicrob Agents; 2008 May; 31(5):434-9. PubMed ID: 18328674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of two methods for testing bacterial susceptibility to antibiotics: disk method and a new semi-automatic method in liquid medium (ABACR procedure) and comparison with the minimal inhibitory concentration (author's transl)].
    Véron M; Ghnassia JC; Berche P; Daoulas-Le Bourdellès F; Avril JL; Fauchère JL; de Meirleire F; Descamps P
    Ann Microbiol (Paris); 1978; 129(4):473-502. PubMed ID: 100035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
    Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
    Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility test of sitafloxacin against resistant gram-negative bacilli isolated from Thai patients by disk diffusion method.
    Thamlikitkul V; Tiengrim S
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S7-12. PubMed ID: 24772575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reevaluation of the cefepime minimal inhibitory concentrations and disk diffusion test zone diameter relationship for a worldwide collection of Enterobacteriaceae enriched for extended-spectrum beta-lactamase-producing organisms.
    Pottumarthy S; Deshpande LM; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):95-9. PubMed ID: 15964496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of the in vitro susceptibility testing results for garenoxacin using six different national methods: report from the garenoxacin international bridging study.
    Jones RN; Gordon KA; Biedenbach DJ
    J Antimicrob Chemother; 2004 Feb; 53(2):258-65. PubMed ID: 14729758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods.
    Almuzara M; Limansky A; Ballerini V; Galanternik L; Famiglietti A; Vay C
    Int J Antimicrob Agents; 2010 Jan; 35(1):68-71. PubMed ID: 19889520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost analysis and antimicrobial susceptibility testing comparing the E test and the agar dilution method in Campylobacter jejuni and Campylobacter coli.
    Valdivieso-García A; Imgrund R; Deckert A; Varughese BM; Harris K; Bunimov N; Reid-Smith R; McEwen S
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):168-74. PubMed ID: 19748428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three methods of susceptibility testing of bacteroidaceae, peptococcaceae and other anaerobes to doxycycline.
    Werner H; Krasemann C; Rodermund OE; Ungerechts J; Schneider B; Wilhelm J
    Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):525-34. PubMed ID: 543353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multi-center evaluation of Showa ceftizoxime disk susceptibility test to discriminate between the strains of methicillin-resistant Staphylococcus aureus (MRSA) and those susceptible (MSSA)].
    Moriyasu I; Igari J; Yamane N; Oguri T; Takahashi A; Tosaka M; Takemori K; Toyoshima S; Minamide W
    Rinsho Byori; 1994 Mar; 42(3):271-7. PubMed ID: 8152163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of inoculum size on sensitivity and specificity of the double-disk synergy test for the detection of wide-spectrum beta-lactamases].
    Bedenić B; Boras A
    Lijec Vjesn; 2001; 123(11-12):293-6. PubMed ID: 11930754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical laboratory approach to estimating the effective administration dose of imipenem/cilastatin. Evaluation of the disk susceptibility test and its interpretation system].
    Matsuo K; Uete T
    Jpn J Antibiot; 1989 Nov; 42(11):2377-92. PubMed ID: 2621780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretation of susceptibility testing of ceftriaxone.
    Squires E; Cleeland R; Christenson J; Boehni E
    Am J Med; 1984 Oct; 77(4C):12-6. PubMed ID: 6093512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical laboratory approach to evaluate administration dose of arbekacin. Reevaluation of in vitro MIC break points in the disk susceptibility test].
    Matsuo K; Uete T
    Jpn J Antibiot; 1994 Aug; 47(8):1041-52. PubMed ID: 7933533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Helicobacter pylori to metronidazole.
    Perna F; Gatta L; Figura N; Ricci C; Tampieri A; Holton J; Miglioli M; Vaira D
    Am J Gastroenterol; 2003 Oct; 98(10):2157-61. PubMed ID: 14572561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
    J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ofloxacin minimum inhibitory concentration versus disk diffusion zone diameter for Salmonella enterica serovar Typhi isolates: problems in the detection of ofloxacin resistance.
    Mandal S; Mandal MD; Pal NK
    Jpn J Infect Dis; 2003; 56(5-6):210-2. PubMed ID: 14695432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.